Enovachem Recalls Estriol USP 0.06 g Due to Impurity Failures
Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling Estriol, USP, (Micronized), 0.06 g, due to out-of-specification impurity test results.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe), as it indicates a potential for temporary or medically reversible adverse health consequences.
Plain-English summary
Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling Estriol, USP, (Micronized), 0.06 g, distributed in Torrance, California. The recall is being conducted because additional testing revealed out-of-specification impurity test results, indicating the product failed to meet required quality standards.
The affected product is identified by NDC #76420-049-36. Specific lot codes and expiration dates associated with the recall include 11061901, 04011903, 04221904, 04241904, 06031902, 07301905, and 09061903, all with an expiration date of 12/31/2020. The product was distributed to six physician's offices within the state of California.
Patients who have received this medication should contact their healthcare provider for further instructions. The FDA has classified this recall as Class II, which means the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The recalled product
- Product
- Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36
- Manufacturer
- Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Category
- Drug — Pharmaceutical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot Code/Exp. Date: 11061901
- 04011903
- 04221904
- 04241904
- 06031902
- 07301905
- 09061903
- EXP 12/31/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Asclemed USA Inc. dba Enovachem Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Asclemed USA Inc. dba Enovachem Pharmaceuticals
See all →- LowEnovachem Recalls Methylprednisolone Tablets Due to Illegible Labeling
FDA (Drugs) · 2021-04-21
- ModerateEnovachem Recalls Estriol USP Micronized 0.24 g Due to Impurity Failures
FDA (Drugs) · 2020-01-15
- ModerateEnovachem Recalls Estriol USP Micronized Due to Impurity Test Failures
FDA (Drugs) · 2020-01-15
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17